Mismatch repair deficiency does not mediate clinical resistance to temozolomide in malignant glioma.

Maxwell, Jill A

Mismatch repair deficiency does not mediate clinical resistance to temozolomide in malignant glioma. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Aug 2008 - 4859-68 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1078-0432

10.1158/1078-0432.CCR-07-4807 doi


Adult
Aged
Aged, 80 and over
Antineoplastic Agents, Alkylating--pharmacology
Base Pair Mismatch
Brain Neoplasms--drug therapy
DNA Mismatch Repair
Dacarbazine--analogs & derivatives
Drug Resistance, Neoplasm
Female
Glioblastoma--genetics
Glioma--drug therapy
Humans
Male
Middle Aged
O(6)-Methylguanine-DNA Methyltransferase--genetics
Temozolomide